Friday, May 24, 2013

NEW DRUGS IN HEMATOLOGIC MALIGNANCIES

1.ABT-199 A BCL-2 INHIBITOR
2.DASATINIB (SRC-ABL INHIBITOR)
3.FOSTAMATINIB (SYK INHIBITOR)
4.IDELALISIB (PI3K INHIBITOR) IN RELAPSED CLL
5.REVLIMID (IMMUNOMODULATOR)
6.OBINUTUZUMAB (ANTI-CD20)
7 IBRUTINIB   inhibitor of Bruton's tyrosine kinase (Btk). CANNOT COMMENT ENOUGH ABOUT IBRUTINIB, WORKS EVERYWHERE IN HEMATOLOGIC MALIGNANCIES!
Post a Comment